PILLAR PACIFIC CAPITAL MANAGEMENT LLC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 274 filers reported holding ARRAY BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.

Quarter-by-quarter ownership
PILLAR PACIFIC CAPITAL MANAGEMENT LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$1,411,000
+84.4%
30,440
-3.1%
0.16%
+79.5%
Q1 2019$765,000
+66.3%
31,400
-2.8%
0.09%
+46.7%
Q4 2018$460,000
-6.3%
32,3000.0%0.06%
+13.2%
Q3 2018$491,000
-9.4%
32,3000.0%0.05%
-15.9%
Q2 2018$542,000
+6.1%
32,300
+3.0%
0.06%
+3.3%
Q1 2018$511,000
+20.8%
31,350
-5.0%
0.06%
+17.3%
Q4 2017$423,000
+2.4%
33,000
-1.8%
0.05%
-1.9%
Q3 2017$413,000
+47.0%
33,6000.0%0.05%
+39.5%
Q2 2017$281,000
-11.9%
33,600
-5.9%
0.04%
-15.6%
Q1 2017$319,000
+1.9%
35,7000.0%0.04%
-6.2%
Q4 2016$313,000
+29.9%
35,7000.0%0.05%
+26.3%
Q3 2016$241,000
+88.3%
35,7000.0%0.04%
+72.7%
Q2 2016$128,000
+21.9%
35,7000.0%0.02%
+22.2%
Q1 2016$105,000
-30.5%
35,7000.0%0.02%
-33.3%
Q4 2015$151,000
-7.4%
35,7000.0%0.03%
-12.9%
Q3 2015$163,000
-36.8%
35,7000.0%0.03%
-31.1%
Q2 2015$258,000
-1.9%
35,7000.0%0.04%
-2.2%
Q1 2015$263,000
+52.9%
35,700
-2.2%
0.05%
+48.4%
Q4 2014$172,000
+31.3%
36,5000.0%0.03%
+29.2%
Q3 2014$131,000
-21.6%
36,5000.0%0.02%
-22.6%
Q2 2014$167,000
-2.9%
36,5000.0%0.03%
-11.4%
Q1 2014$172,000
-6.0%
36,5000.0%0.04%
-2.8%
Q4 2013$183,000
-19.4%
36,5000.0%0.04%
-28.0%
Q3 2013$227,000
+36.7%
36,5000.0%0.05%
+25.0%
Q2 2013$166,00036,5000.04%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
Redmile Group, LLC 17,556,586$215,946,00010.65%
BVF INC/IL 6,402,525$78,751,00010.01%
First Light Asset Management, LLC 1,469,461$18,074,0005.72%
Avoro Capital Advisors LLC 5,353,029$65,842,0005.11%
EcoR1 Capital, LLC 1,250,000$15,375,0002.05%
Cormorant Asset Management, LP 900,000$11,070,0001.96%
NEXTHERA CAPITAL LP 615,437$7,570,0001.95%
Monashee Investment Management LLC 418,000$5,141,0001.94%
Orbimed Advisors 14,182,900$174,450,0001.67%
KOPP INVESTMENT ADVISORS LLC 119,579$1,471,0001.35%
View complete list of ARRAY BIOPHARMA INC shareholders